Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors

References

• McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest 2002; 121: 1155–1158
   PubMed Web of Science ®Google Scholar
• Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003; 41: 1–11
   PubMed Web of Science ®Google Scholar
• Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998; 40: 149–154
   PubMed Web of Science ®Google Scholar
• Narayan S, Henning GT, Ten Haken RK, Sullivan MA, Martel MK, Hayman JA. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004; 44: 79–88
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861–870
   PubMed Web of Science ®Google Scholar
• Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124: 1946–1955
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60: 186–196
   PubMed Web of Science ®Google Scholar
• McGarry RC, Papiez L, Williams M, Whiteford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005; 63: 1010–1015
   PubMed Web of Science ®Google Scholar
• Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 2006; 51: 97–103
   PubMed Web of Science ®Google Scholar
• Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, Yamashita T, Niibe Y, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004; 101: 1623–1631
   PubMed Web of Science ®Google Scholar
• Radiation Therapy Oncology Group. RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer. 2004.
   Google Scholar
• Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thoracic Oncol 2006; 1: 802–809
   PubMed Web of Science ®Google Scholar
• Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp MM, Jr, Rodebaugh R, Weinhous MS, Le QT. Stereotactic radiosurgery for lung tumors:preliminary report of phase I trail. Ann Thoracic Surg 2003; 75(4)1097–1101
   PubMed Web of Science ®Google Scholar
• Brown WT, Perman M, Wu X, . Image guided robotic stereotactic radiosurgery for lung tumors. Robotic Radiosurgery. Vol. I, RF Mould, et al. The CyberKnife Society Press, Sunnyvale, CA 2005; 255–269
   Google Scholar
• Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003; 55(3)724–735
   PubMed Web of Science ®Google Scholar
• Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, Kelly JF. Starkschall G. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 2003; 56: 106–113
   PubMed Web of Science ®Google Scholar
• Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, Carette MF, Rosenwald JC, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000; 48: 1015–1024
   PubMed Web of Science ®Google Scholar
• Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996; 34(2)297–302
   PubMed Web of Science ®Google Scholar
• Fowler JF, Tome WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004; 60(4)1241–1256
   PubMed Web of Science ®Google Scholar
• Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833–4839
   PubMed Web of Science ®Google Scholar
• Slotman BJ, Antonisse IE, Njo KH. Limited field irradiation in early stage (T1-2 N0) non small cell lung cancer. Radiotherap Oncol 1996; 41: 41–44
   PubMed Web of Science ®Google Scholar
• Mehta MP, Wang W, Johnson D, Wagner H, Schiller J, Veeder M, Belani C. Induction chemotherapy followed by standard radiotherapy vs. hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non small cell lung cancer: Phase III study of Eastern Cooperative Oncology Group (ECOG 2597). Int J Radiat Oncol Biol Phys 2003; 57(2 Suppl)S141
   Google Scholar
• Cheung PCF, Yeung LTF, Basrur V, Ung YC, Balogh J, Danjoux CE. Accelerated hypofractionation for early stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 54(4)1014–1023
   PubMed Web of Science ®Google Scholar
• Maguire PD, Marks LB, Sibley GS, Herndon JE, II, Clough RW, Light KL, Hernando ML, Antoine PA, Anscher MS. Gy and beyond: Hyperfractionated accelerated radiotherapy for non small lung cancer. J Clin Oncol 2001; 19(3)705–711
   PubMed Web of Science ®Google Scholar
• Yan D. Adapt radiotherapy to temporal biology targets assessed using biological images. Proceedings of the 14th International Conference on the Use of Computers in Radiotherapy (ICCR). SeoulKorea 2004
   Google Scholar
• Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004; 59: 242–249
   PubMed Web of Science ®Google Scholar
• Fowler JF. Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment - continually rapid proliferation unmasked. Radiother Oncol 1991; 22(3)156–158
   PubMedGoogle Scholar